Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00254228 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of the BrainPort™ Balance Device to Improve Balance in Bilateral Vestibular Hypofunction
A NA study, sponsored by Wicab.
- Terminated
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00254228 is a NA study that was terminated before completion, run by Wicab. The registered enrollment target is 60 participants.
The verdict
NCT00254228, a NA study, was terminated before completion, sponsored by Wicab.
- TERMINATED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the BrainPort™ balance device is safe and effective in the treatment of balance disorders in patients with Bilateral Vestibular Dysfunction.
Interventions
- DEVICE Electrotactile sensory substitution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2005-11 |
| Est. Completion | 2007-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00254228
The ClinicalTrials.gov registry entry for NCT00254228 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wicab, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Electrotactile sensory substitution is the first listed.
NCT00254228 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00254228 about?
NCT00254228 is a clinical study titled "Safety and Efficacy of the BrainPort™ Balance Device to Improve Balance in Bilateral Vestibular Hypofunction". The purpose of this study is to determine whether the BrainPort™ balance device is safe and effective in the treatment of balance disorders in patients with Bilateral Vestibular Dysfunction.
What is the current status of trial NCT00254228?
This trial is currently terminated. It is a NA study. The enrollment target is 60 participants. The study started on 2005-11. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00254228?
The interventions under investigation include: Electrotactile sensory substitution (DEVICE).
Who is sponsoring clinical trial NCT00254228?
This trial is sponsored by Wicab, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.